Skip to main content

Articles

Page 1 of 18

  1. Maternal transmission of human immunodeficiency virus (HIV) commonly occurs from mother to child during pregnancy, delivery, and breastfeeding which accounts for almost all the new HIV infections among childre...

    Authors: Agani Afaya and Aloysia Ispriantari
    Citation: AIDS Research and Therapy 2024 21:11
  2. Acquired Immune Deficiency Syndrome (AIDS) is a highly dangerous infectious disease caused by the Human Immunodeficiency Virus (HIV), a virus that attacks the human immune system. To explore the correlation be...

    Authors: Pengfei Meng, Guichun Zhang, Xiuxia Ma, Xue Ding, Xiyuan Song, Shuyuan Dang, Ruihan Yang and Liran Xu
    Citation: AIDS Research and Therapy 2024 21:10
  3. The Integrated Bio-Behavioural Surveillance Survey of 2022–2023 among key populations report from Zanzibar has been released. The prevalence of HIV is estimated to be 21.1%, 11.4%, and 9.3% among Female Sex Wo...

    Authors: Mansour Maulid Mshenga and Weiming Tang
    Citation: AIDS Research and Therapy 2024 21:9
  4. Studies on antiretroviral therapy (ART) in children living with HIV (CLHIV) are limited due to the small population and low accession rate of ART.

    Authors: Ting Zeng, Xin Chen, Xiao-Yi Zhang, Chao-Xian Lian, Rong-Rong Yang, Li-Ling Yu, Xiao-Kang Liao, Dan-Dan Huang, Yu-Ning Zhang and Hong-Min Cao
    Citation: AIDS Research and Therapy 2024 21:8
  5. Availability of anti-retroviral treatment has changed HIV in to a manageable chronic disease, making effective self-management essential. However, only a few studies in low- and middle-income countries (LMICs)...

    Authors: Tegene Legese Dadi, Anja M. C. Wiemers, Yadessa Tegene, Girmay Medhin and Mark Spigt
    Citation: AIDS Research and Therapy 2024 21:7
  6. Antiretroviral therapy client satisfaction is a significant tool that enables to strengthen the quality of life of the clients. The study aimed to assess the satisfaction of clients with antiretroviral therapy...

    Authors: Bayisa Abdissa, Rahel Abdissa, Jiregna Derega and Senahara Korsa Wake
    Citation: AIDS Research and Therapy 2024 21:6
  7. Human Immunodeficiency Virus (HIV) infection remains a public health concern in many countries. The increased life expectancy in the post-Antiretroviral Therapy (ART) era has led to an increased risk of cardiovas...

    Authors: Mawulorm K. I. Denu, Ritika Revoori, Maame Araba E. Buadu, Oluwakemi Oladele and Kofi Poku Berko
    Citation: AIDS Research and Therapy 2024 21:5
  8. There is limited data on dolutegravir (DTG)-associated weight gain from settings with a dual burden of HIV and overnutrition.

    Authors: Didier M. Mukuna, Tom Decroo and Clara M. Nyapokoto
    Citation: AIDS Research and Therapy 2024 21:4
  9. Malakoplakia is a rare chronic granulomatous disease characterized by the presence of Michaelis-Gutmann bodies (MGBs) within histiocytic aggregates. It predominantly affects immunocompromised individuals, incl...

    Authors: Mohammed Alsaeed, Mohamed Mursi, Nazik Eltayeb, Hadi Kuriry, Salafa Albaghli and Yasir Alrusayni
    Citation: AIDS Research and Therapy 2024 21:3
  10. Empyema caused by Streptococcus constellatus (S. constellatus) is rare in patients with HIV. To analyze the clinical data of a patient living with HIV (PLHIV), who got empyema caused by S. constellatus, invest...

    Authors: Hong-Hong Yang, Mei Li, Qing Yu, Qian Liu and Min Liu
    Citation: AIDS Research and Therapy 2024 21:2
  11. We assessed whether the impact of cabotegravir plus rilpivirine on inflammation reduction differs from that of oral antiretrovirals, using real-world data. Inflammatory biomarkers and lipid profiles were follo...

    Authors: Eisuke Adachi, Makoto Saito, Amato Otani, Michiko Koga and Hiroshi Yotsuyanagi
    Citation: AIDS Research and Therapy 2024 21:1
  12. Low-adherence to Anti-retroviral therapy (ART) negatively affects the clinical, immunological, and virologic outcomes of patients. Adherence is the most important factor in determining Antiretroviral Therapy (...

    Authors: Yihenew Zurbachew, Desta Hiko, Girma Bacha and Hailu Merga
    Citation: AIDS Research and Therapy 2023 20:91
  13. Intensive adherence counseling (IAC) is the global standard of care for people living with human immunodeficiency virus (PLHIV) who have unsuppressed VL after ≥ 6 months of first-line anti-retroviral therapy (...

    Authors: Jonathan Izudi, Barbara Castelnuovo, Rachel King and Adithya Cattamanchi
    Citation: AIDS Research and Therapy 2023 20:90
  14. Major depression is the most common neuropsychiatric disorder among people living with HIV (PLWH) and is predictive of high morbidity and mortality among them. This study estimated the prevalence and explored ...

    Authors: Waheed Adeola Adedeji, Qing Ma, Abiodun Muhammed Raji, Raymond Cha, Olaniran Mudasiru Rasaki, Alan Hutson, Babafemi O. Taiwo, Man E. Charurat, Oyindamola B. Yusuf, Fatai Adewale Fehintola, Oye Gureje and Gene D. Morse
    Citation: AIDS Research and Therapy 2023 20:89
  15. In spite of the global decreasing mortality associated with HIV, adolescents living with HIV (ADLHIV) in sub-Saharan Africa still experience about 50% mortality rate. We sought to evaluate survival rates and d...

    Authors: Nicholas Tendongfor, Joseph Fokam, Collins Ambe Chenwi, Fabrice Léo Tamhouo Nwabo, Armanda Nangmo, Njume Debimeh, Suzie Tetang Ndiang Moyo, Marie Patrice Halle, Anne-Esther Njom-Nlend, Paul Koki Ndombo and Alexis Ndjolo
    Citation: AIDS Research and Therapy 2023 20:88
  16. Surging HIV prevalence across countries of Central and Eastern Europe (CEE) is largely a result of poor HIV care engagement and a lack of comprehensive support for key populations. This is fostered by widespre...

    Authors: Ana-Maria Schweitzer, Arian Dišković, Veronica Krongauz, Julie Newman, Janez Tomažič and Nina Yancheva
    Citation: AIDS Research and Therapy 2023 20:87
  17. In 2016, the Canada-International HIV and Rehabilitation Research Collaborative established a framework of research priorities in HIV, aging and rehabilitation. Our aim was to review and identify any new emerg...

    Authors: Kelly K. O’Brien, Francisco Ibáñez-Carrasco, Kelly Birtwell, Graeme Donald, Darren A. Brown, Andrew D. Eaton, Bakita Kasadha, Emma Stanmore, Natalie St. Clair-Sullivan, Liam Townsend, Jaime H. Vera and Patricia Solomon
    Citation: AIDS Research and Therapy 2023 20:86
  18. This case series of 5 patients with severely necrotic mpox highlights the predominantly necrotic nature of lesions seen in cases of severe mpox as shown by skin and lung biopsy, as well as the extensive dissem...

    Authors: Sandra Rajme-López, Ever A. Corral-Herrera, Andrea C. Tello-Mercado, Karen M. Tepo-Ponce, Raúl E. Pérez-Meléndez, Ángela Rosales-Sotomayor, Grecia Figueroa-Ramos, Karla López-López, Judith G. Domínguez-Cherit, Oswaldo San-Martín-Morante, Marcela Saeb-Lima, Armando Gamboa-Domínguez, Alfredo Ponce-de-León, Brenda Crabtree-Ramírez, Pilar Ramos-Cervantes and Guillermo M. Ruíz-Palacios
    Citation: AIDS Research and Therapy 2023 20:85
  19. Globally, over 40 million lives have been claimed by HIV/AIDS. In Ghana, more than 350,000 people are living with HIV. Non-disclosure of HIV status is a major barrier to HIV/AIDS eradication; yet, little is kn...

    Authors: Robert Kaba Alhassan, Jerry John Nutor, Akua Gyamerah, Emily Boakye-Yiadom, Emmanuel Kasu, Evelyn Acquah and Emmanuel Doe
    Citation: AIDS Research and Therapy 2023 20:84
  20. The World Health Organization (WHO) recommends an evidence-based package of care to reduce mortality and morbidity among people with advanced HIV disease (AHD). Adoption of these recommendations by national gu...

    Authors: Thomas C. Scheier, Nabila Youssouf, Mosepele Mosepele, Cecilia Kanyama, Olukemi Adekanmbi, Sulaiman Lakoh, Conrad K. Muzoora, Graeme Meintjes, Dominik Mertz, John W. Eikelboom and Sean Wasserman
    Citation: AIDS Research and Therapy 2023 20:83
  21. Human immunodeficiency virus (HIV) infection is associated with an elevated incidence of cervical cancer, and accelerated disease progression, but the underlying mechanisms are not well understood. This study ...

    Authors: Peizhi Wang, Baojun Yang, Huang Huang, Peiyi Liang, Bin Long, Lin Chen, Lijie Yang, Lianhua Tang, Liping Huang and Huichao Liang
    Citation: AIDS Research and Therapy 2023 20:82
  22. Gay, bisexual, and other men who have sex with men (GBMSM) experience a high prevalence of psychosocial health problems, such as harmful substance use and depression, as well as being disproportionately affect...

    Authors: Rosalie Hayes, Will Nutland, Michael Rayment, Sonali Wayal, Vanesa Apea, Amanda Clarke, Alan McOwan, Ann Sullivan, Monica Desai, Andrew Jajja, Brian Rice, Rob Horne, Sheena McCormack and Mitzy Gafos
    Citation: AIDS Research and Therapy 2023 20:81
  23. The Russian Federation’s invasion in Ukraine has resulted social hardship, millions of internally displaced persons, the destruction of medical infrastructure, and limited access to HIV services. There is no a...

    Authors: Olena Karagodina, Oksana Kovtun, Myroslava Filippovych and Oleksandr Neduzhko
    Citation: AIDS Research and Therapy 2023 20:80
  24. People with human immunodeficiency virus have an increased risk of developing AIDS-defining malignancies including Burkitt lymphoma. Survival outcomes in HIV-associated Burkitt lymphoma remain worse than non-H...

    Authors: Ashley M. Tuin, Clare M. Wieland, Elizabeth J. Dort, Danielle B. Dilsaver and Manasa Velagapudi
    Citation: AIDS Research and Therapy 2023 20:79
  25. Psychological discomfort and sleep problems are considered separate disorders. Due to the high prevalence of both disorders among people living with HIV (PLWH), this study was designed to evaluate how those ch...

    Authors: Mohammad Ebrahimzadeh Mousavi, Safieh Mohammad Nejad, Maryam Shafaati, Rosa Mykyta-Chomsky, Samaneh Akbarpour and Fatemeh Hadavandsiri
    Citation: AIDS Research and Therapy 2023 20:78
  26. Pre-exposure prophylaxis is the use of antiretroviral medications by HIV-negative individuals to prevent infection before exposure. Ethiopia has made progress in reducing new HIV infections, but the burden rem...

    Authors: Belayneh Fentahun Shibesh, Aragaw Bitew Admas, Amarech Wondie Lake, Samuel Befekadu Getu and Daniel Tarekegn Worede
    Citation: AIDS Research and Therapy 2023 20:77
  27. With effective antiretroviral therapy (ART), many persons living with HIV (PLHIV) live to old age. Caring for aged PLHIV necessitates the engagement of caregivers and patients to establish agreed-upon goals of...

    Authors: Scovia Nalugo Mbalinda, Derrick Amooti Lusota, Martin Muddu, David Musoke and Mathew Nyashanu
    Citation: AIDS Research and Therapy 2023 20:76
  28. HIV seroprevalence in Nigeria is increasing among men who have sex with men (MSM) from 14% to 2007 to 23% in 2014, threatening progress towards ending the epidemic in the country. Expanding access to HIV testi...

    Authors: Lisa R. Hirschhorn, Adedotun Adetunji, Aima A. Ahonkhai, Bibilola Oladeji, Olutosin A. Awolude, Lisa M. Kuhns, Jude Onumabor, Kehinde M. Kuti, Olayinka Omigbodun, Amy K. Johnson, Ogochukwu Okonkwor, Babafemi Taiwo and Robert Garofalo
    Citation: AIDS Research and Therapy 2023 20:75
  29. The purpose of this study is to investigate the incidence of determinants for virologic failure and to identify predisposing factors to enhance treatment efficacy. Tackling this global public health issue is t...

    Authors: SeyedAhmad SeyedAlinaghi, Amir Masoud Afsahi, Ali Moradi, Zohal Parmoon, Pedram Habibi, Pegah Mirzapour, Mohsen Dashti, Afsaneh Ghasemzadeh, Elaheh Karimi, Foziye Sanaati, Zahra Hamedi, Ayoob Molla, Esmaeil Mehraeen and Omid Dadras
    Citation: AIDS Research and Therapy 2023 20:74
  30. Few studies have examined preventative behaviour practices with respect to COVID-19 among people living with HIV (human immunodeficiency virus). Using a cross-sectional survey from a Canadian Institutes of Hea...

    Authors: Keely Hammond, Terry Lee, Branka Vulesevic, Joel Singer, Judy Needham, Ann N. Burchell, Hasina Samji, Sharon Walmsley, Mark Hull, Mohammad-Ali Jenabian, Jean-Pierre Routy, Shari Margolese, Enrico Mandarino, Aslam H. Anis, Curtis L. Cooper and Cecilia T. Costiniuk
    Citation: AIDS Research and Therapy 2023 20:73
  31. The COVID-19 pandemic has had a major effect on HIV-related healthcare services. Zanzibar has experienced several interruptions of HIV services in the areas of testing and counselling, prevention of mother-to-...

    Authors: Mansour Maulid Mshenga, Farhat Jowhar Khalid, Shaaban Hassan Haji, Tatu Bilali Ali, Khadija Abbas Mohamed and Damian Jeremia Damian
    Citation: AIDS Research and Therapy 2023 20:72
  32. There has been growing interest in understanding the drivers of health outcomes, both in developed and developing countries. The drivers of health outcomes, on the other hand, are the factors that influence th...

    Authors: Ndumiso Tshuma, Elakpa Daniel Ngbede, Tawanda Nyengerai, Oliver Mtapuri, Sangiwe Moyo, David D. Mphuthi and Peter Nyasulu
    Citation: AIDS Research and Therapy 2023 20:71
  33. Key populations (KPs) are particularly vulnerable to HIV infection and efforts to prevent HIV infections among KPs have been less successful, largely due to existing laws and legislation that classify the grou...

    Authors: Duah Dwomoh, Issata Wurie, Yvonne Harding, Kojo Mensah Sedzro, Joseph Kandeh, Henry Tagoe, Christabel Addo, Daniel Kojo Arhinful, Abdul Rahman Cherinoh Sessay, James Lahai Kamara, Kemoh Mansaray and William Kwabena Ampofo
    Citation: AIDS Research and Therapy 2023 20:70
  34. Transgender women who sell sex (TWSS) experience high rates of HIV acquisition. Antiretrovirals for pre-exposure prophylaxis (PrEP) represent an efficacious HIV prevention strategy. The social and structural f...

    Authors: Erin E. Cooney, Katherine H. A. Footer, Jennifer L. Glick, Anna Passaniti, Meridian Howes and Susan G. Sherman
    Citation: AIDS Research and Therapy 2023 20:69
  35. Uganda adopted and implemented the Universal Test and Treat (UTT) guidelines in 2017, which require HIV-infected persons to be initiated on antiretroviral therapy (ART) at any CD4 + cell count, and to be routi...

    Authors: Regina Ndagire, Rachel Nante Wangi, Kevin Ouma Ojiambo, Joanita Nangendo, Juliet Nakku, Herbert Muyinda and Fred C. Semitala
    Citation: AIDS Research and Therapy 2023 20:68
  36. Suboptimal antiretroviral (ART) adherence can lead to virologic failure with consequent HIV-1 resistance. Tenofovir diphosphate (TFV-DP) in dried blood spots (DBS) is a powerful biomarker of cumulative adheren...

    Authors: Y. Singh, J. Castillo-Mancilla, R. Madimabe, L. Jennings, C. M. Ferraris, R. N. Robbins, P. L. Anderson, R. H. Remien and C. Orrell
    Citation: AIDS Research and Therapy 2023 20:67
  37. Human immunodeficiency virus type 1 (HIV-1) is the primary epidemic strain in China. Its genome contains two regulatory genes (tat and rev), three structural genes (gag, pol, and env), and four accessory genes (n...

    Authors: Shanling Liu, Ting Guo, Jinwei Hu, Weiliang Huang, Pengfei She and Yong Wu
    Citation: AIDS Research and Therapy 2023 20:66
  38. The Uganda Ministry of Health issued restrictive guidelines on the use of dolutegravir (DTG) in persons stratified to have a heightened risk of diabetes mellitus. This followed multiple reports of persons with...

    Authors: Frank Mulindwa, Barbara Castelnuovo, Nele Brusselaers, Martin Nabwana, Robert Bollinger, Allan Buzibye, Eva Laker Agnes Odongpiny, Ronald Kiguba and Jean-Marc Schwarz
    Citation: AIDS Research and Therapy 2023 20:65
  39. A substantial risk of contracting Human immunodeficiency virus (HIV) exists among men who have sex with men (MSM), and HIV infection rates have been rising. This study aimed to analyze the factors influencing ...

    Authors: Han Jiang, Wei He, Haiying Pan and Xiaoni Zhong
    Citation: AIDS Research and Therapy 2023 20:64
  40. Despite increasing effort for treating primary central nervous system lymphoma (PCNSL), the prognosis of human immunodeficiency virus (HIV) -related PCNSL was still unsatisfactory. There is currently a lack of...

    Authors: Ying Zhou, Xiaoxue Wang, Xuyong Lin, Jun Wang, Xiaojing Yan and Ying Wen
    Citation: AIDS Research and Therapy 2023 20:63
  41. Long-acting injectable formulations for HIV infection have been approved and are now available in Japan. Although not currently recommended as first-line drugs in Japanese or overseas guidelines, use of such f...

    Authors: Masashi Ishihara, Shinichi Hikasa, Mariko Tsukiji, Yusuke Kunimoto, Kazuko Nobori, Takeshi Kimura, Kenta Onishi, Yuki Yamamoto, Kyohei Haruta, Yohei Kashiwabara, Kenji Fujii, Shota Shimabukuro, Daichi Watanabe, Hisashi Tsurumi and Akio Suzuki
    Citation: AIDS Research and Therapy 2023 20:62
  42. Managing multidrug-resistant (MDR) HIV infections in children is particularly challenging due to the lack of experience with new drugs in the pediatric setting. Second-line albuvirtide (ABT) with an optimized ...

    Authors: Wei Tang, Xiao-yun Song, Jing Cao, Chun Liu and Fang Zheng
    Citation: AIDS Research and Therapy 2023 20:60
  43. Low health literacy (HL) among people living with HIV (PLWHIV) encounter more disease related complications, more difficulty understanding health-related information and low adherence. Considering that, the HL...

    Authors: Lotte Ørneborg Rodkjaer, Merete Storgaard, Nanna Toxvig Sørensen and Liv Marit Valen Schougaard
    Citation: AIDS Research and Therapy 2023 20:59
  44. The increased survival provided by the access, development, and evolution of antiretroviral drugs (ARV) greatly increased the life expectancy of people living with HIV (PWH). This has also led to an increased ...

    Authors: Robson Pierre Nascimento da Silva, Luana M. S. Marins, Lusiele Guaraldo, Paula Mendes Luz, Sandra W. Cardoso, Ronaldo I. Moreira, Vanessa da Gama Oliveira, Valdilea G. Veloso, Beatriz Grinsztejn, Rita Estrela and Thiago S. Torres
    Citation: AIDS Research and Therapy 2023 20:57
  45. HIV infection increases the risk of type 2 diabetes and may influence its phenotypic profile. In this study, we aimed to compare the anthropometric and metabolic characteristics of HIV-infected and uninfected ...

    Authors: Davis Kibirige, Isaac Sekitoleko, Noela Owarwo, Irene Andia-Biraro and William Lumu
    Citation: AIDS Research and Therapy 2023 20:56
  46. Antiretroviral therapy (ART) has led to a decline in human immunodeficiency virus (HIV)-related mortality, but comorbidities, including organ dysfunction, are increasingly the focus of care. Heart transplant (...

    Authors: Thamer A. Almangour, Preston T. Skersick, Amanda Corbett, Jo E. Rodgers, Patricia P. Chang and Claire E. Farel
    Citation: AIDS Research and Therapy 2023 20:55
  47. South Africa is reported to have the highest burden of HIV with an estimated 8.2 million people living with HIV (PLHIV) in 2021- despite adopting the World Health Organisation (WHO) universal HIV test and trea...

    Authors: Abenathi Mcinziba, Peter Bock, Graeme Hoddinott, Janet Seeley, Virginia Bond, Sarah Fidler and Lario Viljoen
    Citation: AIDS Research and Therapy 2023 20:54
  48. Varicella-Zoster virus (VZV) vasculopathy occasionally occurs in immunocompromised patients and is difficult to treat. The risk factor and optimal therapy remain unclear. Patients with human immunodeficiency v...

    Authors: Kazuhiro Ishikawa, Fujimi Kawai and Nobuyoshi Mori
    Citation: AIDS Research and Therapy 2023 20:53